Timothy Smith

3.7k total citations
114 papers, 3.0k citations indexed

About

Timothy Smith is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cancer Research. According to data from OpenAlex, Timothy Smith has authored 114 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Radiology, Nuclear Medicine and Imaging, 34 papers in Molecular Biology and 33 papers in Cancer Research. Recurrent topics in Timothy Smith's work include Cancer, Hypoxia, and Metabolism (28 papers), Radiopharmaceutical Chemistry and Applications (15 papers) and Medical Imaging Techniques and Applications (14 papers). Timothy Smith is often cited by papers focused on Cancer, Hypoxia, and Metabolism (28 papers), Radiopharmaceutical Chemistry and Applications (15 papers) and Medical Imaging Techniques and Applications (14 papers). Timothy Smith collaborates with scholars based in United Kingdom, United States and Egypt. Timothy Smith's co-authors include Martin O. Leach, W. J. L. Buyers, Robert H. Abeles, V. R. McCready, Laurent Trembleau, A. Welch, Su Phyu, J. Glaholm, Tanya MacNeil and J. S. Reid and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Timothy Smith

111 papers receiving 2.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Timothy Smith 997 837 540 455 353 114 3.0k
Brigitte Guérin 1.1k 1.1× 623 0.7× 159 0.3× 329 0.7× 335 0.9× 151 4.6k
Harold G. Parkes 960 1.0× 913 1.1× 426 0.8× 338 0.7× 217 0.6× 99 3.3k
Antony D. Gee 1.7k 1.7× 2.1k 2.5× 288 0.5× 347 0.8× 605 1.7× 215 7.1k
Simon M. Ametamey 2.0k 2.0× 2.3k 2.7× 545 1.0× 307 0.7× 771 2.2× 219 6.5k
Pasquina Marzola 1.1k 1.1× 749 0.9× 304 0.6× 538 1.2× 255 0.7× 144 3.4k
Michael Honer 1.5k 1.5× 1.4k 1.7× 237 0.4× 175 0.4× 681 1.9× 72 4.2k
Hiroyuki Kimura 1.1k 1.1× 604 0.7× 436 0.8× 230 0.5× 415 1.2× 163 3.1k
Manabu Abe 893 0.9× 324 0.4× 396 0.7× 1.2k 2.6× 391 1.1× 342 6.9k
Ralf Bergmann 1.3k 1.3× 1.6k 1.9× 278 0.5× 275 0.6× 1.6k 4.6× 222 4.4k
Federico Boschi 751 0.8× 524 0.6× 187 0.3× 395 0.9× 300 0.8× 139 2.8k

Countries citing papers authored by Timothy Smith

Since Specialization
Citations

This map shows the geographic impact of Timothy Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Smith more than expected).

Fields of papers citing papers by Timothy Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Smith. The network helps show where Timothy Smith may publish in the future.

Co-authorship network of co-authors of Timothy Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Smith. A scholar is included among the top collaborators of Timothy Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Smith. Timothy Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lane, Brian R., Leo Zeef, Peter Hoskin, et al.. (2025). Gene Expression in Muscle-Invasive and Non-Muscle-Invasive Bladder Cancer Cells Exposed to Hypoxia. Cancers. 17(16). 2624–2624. 1 indexed citations
2.
Smith, Timothy, Kimberley J. Reeves, F. J. Currell, et al.. (2024). Immune effects of α and β radionuclides in metastatic prostate cancer. Nature Reviews Urology. 21(11). 651–661. 7 indexed citations
3.
Smith, Danielle, et al.. (2024). CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer. Nature Reviews Urology. 22(1). 55–65. 4 indexed citations
5.
Buchanan, C., Eric O. Aboagye, L. J. Evitts, M.J.D. Rushton, & Timothy Smith. (2024). Modelling Potential Candidates for Targeted Auger Therapy. SHILAP Revista de lepidopterología. 4(4). 711–723. 1 indexed citations
6.
Reardon, Mark, B. Bibby, Niluja Thiruthaneeswaran, et al.. (2024). Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 121(3). 752–760.
8.
Cabello, Gema, Abbie C. Mclaughlin, Laurent Trembleau, et al.. (2018). Physicochemical Tools: Toward a Detailed Understanding of the Architecture of Targeted Radiotherapy Nanoparticles. ACS Applied Bio Materials. 1(5). 1639–1646. 5 indexed citations
9.
Phyu, Su, Chih‐Chung Tseng, & Timothy Smith. (2018). CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor. Magnetic Resonance Materials in Physics Biology and Medicine. 32(2). 227–235. 9 indexed citations
10.
Smith, Timothy, et al.. (2017). Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism. BioMed Research International. 2017. 1–7. 1 indexed citations
11.
Smith, Timothy, et al.. (2016). Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.. PubMed. 36(1). 87–93. 16 indexed citations
12.
Fleming, Ian N., et al.. (2014). Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α. Breast Cancer Research and Treatment. 144(2). 241–248. 15 indexed citations
13.
Smith, Timothy, M. Virginia C. L. Appleyard, Sheila Sharp, et al.. (2012). Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters. Cancer Chemotherapy and Pharmacology. 71(2). 473–480. 17 indexed citations
15.
Smith, Timothy. (2010). Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging. British Journal of Radiology. 83(992). 638–644. 21 indexed citations
16.
Smith, Timothy. (2009). Influence of chemoresistance and p53 status on fluoro-2-deoxy-d-glucose incorporation in cancer. Nuclear Medicine and Biology. 37(1). 51–55. 8 indexed citations
17.
Roshak, Amy, Brian Bolognese, Patricia L. Podolin, et al.. (2000). Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis. Journal of Pharmacology and Experimental Therapeutics. 295(3). 1061–1069. 30 indexed citations
18.
Liao, M J, N. Lee, Musaddeq Hussain, et al.. (1994). Distribution of Interferon-α 2 Genes in Humans. Journal of Interferon Research. 14(4). 183–185. 10 indexed citations
19.
Smith, Timothy, et al.. (1991). The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. British Journal of Cancer. 64(5). 821–826. 72 indexed citations
20.
Smith, Timothy, et al.. (1991). A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. British Journal of Cancer. 63(4). 514–516. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026